ST
CLVS

Spot Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Spot Trading’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,426
Closed -$93.9K – 3937
2016
Q1 		$123K Buy
+6,426
New +$136K ﹤0.01% 2477
2015
Q4 		– Sell
-1,645
Closed -$151K – 4199
2015
Q3 		$151K Sell
1,645
-2,128
-56% -$184K ﹤0.01% 2854
2015
Q2 		$332K Buy
3,773
+3,718
+6,760% +$318K ﹤0.01% 2387
2015
Q1 		$4K Buy
+55
New +$3.88K ﹤0.01% 3683
2014
Q2 		– Sell
-3,233
Closed -$167K – 4907
2014
Q1 		$224K Buy
+3,233
New +$237K ﹤0.01% 3073
2013
Q4 		– Sell
-5,473
Closed -$333K – 4403
2013
Q3 		$333K Buy
+5,473
New +$388K ﹤0.01% 2697

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return